![](/img/cover-not-exists.png)
Does Baseline Body Mass Index, Fasting Blood Sugar, and High-Sensitivity C-Reactive Protein Influence the Efficacy of Adding Ezetimibe to Atorvastatin Versus Doubling the Atorvastatin Dose in Moderately High and High Coronary Heart Disease Risk Patients?
Harold Edward Bays, Scott Conard, Lawrence A. Leiter, Steven Bird, Arvind K. Shah, Jianxin Lin, Robert S. Lowe, Andrew M. TershakovecVolume:
3
Year:
2009
Language:
english
DOI:
10.1016/j.jacl.2009.04.027
File:
PDF, 268 KB
english, 2009